Biohaven Ltd. Files 8-K on Financials
Ticker: BHVN · Form: 8-K · Filed: May 12, 2025 · CIK: 1935979
| Field | Detail |
|---|---|
| Company | Biohaven Ltd. (BHVN) |
| Form Type | 8-K |
| Filed Date | May 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K
TL;DR
Biohaven Ltd. dropped its 8-K, check the financials.
AI Summary
Biohaven Ltd. filed an 8-K on May 12, 2025, reporting on its Results of Operations and Financial Condition, and filing Financial Statements and Exhibits. The company, formerly known as Biohaven Research Ltd. until June 29, 2022, is incorporated in the British Virgin Islands and headquartered in New Haven, Connecticut.
Why It Matters
This filing provides investors with crucial updates on Biohaven Ltd.'s financial performance and condition, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate operational or financial distress.
Key Players & Entities
- Biohaven Ltd. (company) — Registrant
- Biohaven Research Ltd. (company) — Former company name
- May 12, 2025 (date) — Date of report
- 215 Church Street, New Haven, Connecticut 06510 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Biohaven Ltd.?
The primary purpose is to report on Biohaven Ltd.'s Results of Operations and Financial Condition, and to file Financial Statements and Exhibits.
When was Biohaven Ltd. previously known by another name?
Biohaven Ltd. was formerly known as Biohaven Research Ltd. until June 29, 2022.
Where is Biohaven Ltd. incorporated?
Biohaven Ltd. is incorporated in the British Virgin Islands.
What is the address of Biohaven Ltd.'s principal executive offices?
The address of Biohaven Ltd.'s principal executive offices is c/o Biohaven Pharmaceuticals, Inc., 215 Church Street, New Haven, Connecticut 06510.
What is the telephone number for Biohaven Ltd.?
Biohaven Ltd.'s telephone number is (203) 404-0410.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 12, 2025 regarding Biohaven Ltd. (BHVN).